Clinical Trial Update: Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

View source ↗

Summary

Completed clinical trial update reporting genetic analyses of age-related macular degeneration patients who responded to ranibizumab but were resistant to aflib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)
• Lucentis (ranibizumab)

Snippet

Sponsor: Associated Retinal Consultants, Michigan | Conditions: Age-Related Macular Degeneration | Status: COMPLETED